UCB
The Characterisation Project Lead will advance innovative therapies by enabling characterization strategies that support product understanding and quality. This role combines technical expertise with project coordination to generate, document, and communicate critical knowledge for programs aimed at creating meaningful outcomes for patients with severe diseases. The position involves leading biological characterisation activities, designing characterization studies, and managing project priorities and stakeholder communications.
Headquarters
Brussels, Brussels, Belgium
Company Size
5001-10000 employees
Founded
1928
UCB a global biopharmaceutical leader focuses on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for UCB.
UCB didn’t post a salary, so this is our estimate from similar listings.
Senior / Principal Biological Characterisation Scientist
Oracle
Senior / Principal Biological Characterisation Scientist
Oracle
Lead Analytical Scientist - Mass Spectrometry Scientist
Lonza
Scientist, Bioconjugation
Dyne Therapeutics
Senior Scientist – Mass Spectrometry (MS)
CSL Behring Australia
Extended Characterisation Europe Team Member
GSK plc